Skip to main content
See every side of every news story
Published loading...Updated

FDA blocked publication of COVID, shingles vaccine safety studies: Report

Agency scientists found serious side effects were rare, but top officials blocked release of studies on millions of vaccine recipients.

  • The U.S. Food and Drug Administration blocked publication of multiple safety studies on Covid and shingles vaccines, which found serious side effects to be very rare, according to a Health and Human Services spokesperson.
  • Under Health and Human Services Secretary Robert F. Kennedy Jr.'s leadership, federal agencies have softened Covid shot recommendations and reduced vaccine research, including blocking information supporting vaccine safety.
  • Several Covid vaccine safety studies accepted by medical journals were withdrawn, and abstracts on the shingles vaccine Shingrix were not approved for submission to a drug safety conference.
  • FDA officials stated that some studies were withdrawn due to authors drawing broad conclusions unsupported by data, with the shingles study's design falling outside the agency's purview.
Insights by Ground AI

15 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 46% of the sources lean Left, 46% of the sources are Center
46% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Forbes broke the news in United States on Tuesday, May 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal